What is the recommended treatment for typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Typhoid Fever Treatment Guidelines

Ceftriaxone is the first-line treatment for typhoid fever due to its high efficacy and lower resistance rates, particularly in regions with high fluoroquinolone resistance. 1

First-Line Treatment Options

Ceftriaxone

  • Recommended as first-line empiric treatment by the World Health Organization 1
  • Dosage: 50-80 mg/kg/day for 7-10 days 1
  • Advantages:
    • High efficacy with reliable sensitivity patterns globally
    • Suitable for severe infections or when oral therapy isn't possible
    • Safe alternative during pregnancy 1

Azithromycin

  • Excellent alternative first-line option 1
  • Advantages:
    • Lower risk of clinical failure compared to fluoroquinolones
    • Lower relapse rates (<3%) compared to ceftriaxone (<8%) 1
    • Preferred for children and pregnant women due to safety profile 1

Treatment Algorithm Based on Resistance Patterns

  1. For fully sensitive strains:

    • Azithromycin as first choice
    • Alternatives: Fluoroquinolones, chloramphenicol, amoxicillin, trimethoprim-sulfamethoxazole 1
  2. For multidrug-resistant strains:

    • Fluoroquinolones (if susceptible) or cefixime
    • Alternative: Azithromycin 1
  3. For quinolone-resistant strains:

    • Azithromycin or ceftriaxone
    • Alternative: Cefixime 1

Important Treatment Considerations

  • Treatment duration: Continue for 14 days to reduce relapse risk 1
  • Expected response: Clinical improvement typically occurs within 48-72 hours; fever clearance time is usually <4 days with appropriate treatment 1
  • Monitoring: Closely observe for clinical response, particularly when using cefixime which has higher failure rates (4-37.6%) compared to other options 1

Antimicrobial Resistance Concerns

  • More than 70% of Salmonella typhi isolates imported to the UK are resistant to fluoroquinolones 1
  • Ciprofloxacin is FDA-approved for typhoid fever but should be used with caution due to increasing resistance, particularly in South and Southeast Asia 2, 1
  • Using ciprofloxacin discs alone to determine Salmonella typhi sensitivity is unreliable; the organism should also be sensitive to nalidixic acid on disc testing 1

Special Populations

  • Pregnant women: Ceftriaxone is considered safe and particularly useful for severe infections 1
  • Children: Azithromycin is preferred due to its safety profile; avoid fluoroquinolones when possible 1

Comparative Efficacy

  • A Cochrane review found ceftriaxone to be an effective treatment for adults and children with enteric fever, with few adverse effects 3
  • A randomized controlled trial comparing azithromycin and ceftriaxone in children showed high cure rates for both: 91% for azithromycin and 97% for ceftriaxone 4
  • Gatifloxacin and azithromycin showed similar efficacy in a randomized controlled trial, with median fever clearance time of 106 hours in both treatment arms 5

Prevention

  • Typhoid vaccination is recommended for travelers to endemic areas
  • Proper hand hygiene and food safety practices are essential
  • Avoid high-risk foods and beverages in endemic areas 1

Common Pitfalls to Avoid

  • Using fluoroquinolones empirically without considering local resistance patterns
  • Relying on the serological Widal test for diagnosis due to its poor sensitivity and specificity 1
  • Using antimotility agents in patients with high fever or blood in stool 1
  • Stopping treatment early, which can lead to relapse 1
  • Using ciprofloxacin in areas with known high resistance rates

References

Guideline

Typhoid Fever Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.

The Cochrane database of systematic reviews, 2022

Research

Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.